212 F.3d 1241 (Fed. Cir. 2000), 99-1365, Bayer AG and Bayer v Elan Pharm.
Linked as:
Extract
212 F.3d 1241 (Fed. Cir. 2000), 99-1365, Bayer AG and Bayer v Elan Pharm.
No longer available (Autolink)
See the full content of this document
This document cites
- US Code - 35 U.S.C. § 103 Conditions For Patentability; Non-Obvious Subject Matter
- US Code - 35 U.S.C. § 112 Specification
- US Code - 35 U.S.C. § 271 Infringement of Patent
- Code of Federal Regulations - Content and format of an application
- Code of Federal Regulations - Supplements and other changes to an approved NDA